Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Cancer Res. 2019 May 29;79(19):5022–5033. doi: 10.1158/0008-5472.CAN-19-0153

Figure 4. Analysis of immune pathway deregulation and patient outcomes in TCGA LUAD.

Figure 4.

A) Heatmap of gene expression scores of 16 immune-related pathways in TCGA LUAD and normal lung samples. B-C) Kaplan-Meier survival curves of stage I (B) and stage II and higher (C) patients from the groups identified in (A).